{
    "eid": "2-s2.0-84982994844",
    "title": "Serum microRNA-34a is potential biomarker for inflammation in nonalcoholic fatty liver disease",
    "cover-date": "2016-04-01",
    "subject-areas": [
        {
            "$": "General Biochemistry",
            "@code": "1300"
        },
        {
            "$": "General Medicine",
            "@code": "2700"
        }
    ],
    "keywords": [
        "Biomarker",
        "MicroRNA-34a",
        "Non-alcoholic fatty liver disease"
    ],
    "authors": [
        "Puth Muangpaisarn"
    ],
    "citedby-count": 7,
    "ref-count": 26,
    "ref-list": [
        "Nonalcoholic fatty liver disease: A review and update",
        "Nonalcoholic steatohepatitis",
        "The spectrum expanded: Cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease",
        "Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome",
        "The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology",
        "Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma",
        "Design and validation of a histological scoring system for nonalcoholic fatty liver disease",
        "Validation of the non-alcoholic fatty liver disease activity score",
        "Sampling variability of liver biopsy in nonalcoholic fatty liver disease",
        "Liver biopsy",
        "Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity",
        "MicroRNAs in metabolism and metabolic disorders",
        "MicroRNAs in liver disease",
        "Emerging role of microRNAs in liver diseases",
        "Dual role of microRNAs in NAFLD",
        "MiR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease",
        "microRNA-34 family and treatment of cancers with mutant or wild-type p53 (Review)",
        "Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease",
        "Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver",
        "Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease",
        "Targeting the circulating microRNA signature of obesity",
        "Systematic review with meta-analysis: Non-invasive assessment of non-alcoholic fatty liver disease - The role of transient elastography and plasma cytokeratin-18 fragments",
        "miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting",
        "Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver",
        "Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver",
        "MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Rajavithi Hospital",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}